TGTX FY 2017 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$152,381+0.0% YoY

Gross Profit

$70,02646.0% margin

Operating Income

-$119M-77904.6% margin

Net Income

-$118M-77749.9% margin

EPS (Diluted)

$-1.91

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$94M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$97M

Total Liabilities

$97M

Stockholders' Equity

$67M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152,381	$152,381	+0.0%
Gross Profit	$70,026	$89,421	-21.7%
Operating Income	-$119M	-$79M	-50.3%
Net Income	-$118M	-$78M	-51.4%